Skip to main content
Premium Trial:

Request an Annual Quote

NuTec to Open UK-based Office to Tap European Market

NEW YORK, March 15 – Software developer NuTec Sciences announced plans Thursday to make a push into the European life sciences market.

The company said its new office, NuTec Sciences Limited, would be located near Manchester, UK, and named Stephane Labonte managing director in charge of growing NuTec’s life science business and its energy services division in Europe.

“The expansion of operations into Europe reflects the success of our US business model,” Michael Mott, vice president of marketing for NuTec. “By leveraging our core competencies in informatics, integrated software, and massively parallel supercomputing technology, we are creating highly specialized products for the marketplace.”

The company, which hopes to form alliances with British labs and universities, is also planning to install a massively parallel supercomputer in Europe starting sometime within the next year.

In December NuTec said it had contracted IBM to build a 7.5-teraflop computing cluster that NuTec’s life science unit in Atlanta would use to study genes’ role in disease.

NuTec develops desktop software applications and massively parallel supercomputing technology.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.